Natco has, over the years, developed a knack for manufacturing
complex generic products with few competitors, especially for the US market.
Posts tagged Natco Pharma
Natco has the ability to focus on blockbusters which are capable of generating robust cash flows. Buy for target price of 1305 (50% upside): ICICI Direct
Five High-Quality “Fallen Angels” Mid-Cap Stocks To Buy Now For Multibagger Gains
Outlook Business has persuaded leading experts to recommend five high-quality mid-cap stocks which are quoting at reasonable valuations. These stocks are powerhouses and we have to take advantage of the situation to tuck into them ASAP
Top 10 Mid-Cap Stocks To Buy For 2018 By Karvy
Karvy has commissioned its best minds to cherry-pick the best 10 mid-cap stocks and prepare a model portfolio for us. As expected, the experts have done a splendid job in their stock selection
Sharekhan Recommends Model Portfolio Of Ten Blue-Chip “Diwali Dhamaka” Stocks
Sharekhan’s recommendations for Diwali 2016 have yielded a magnificent gain of 42%. They have assured that the recommendations for 2017 will yield similar mega returns
Top 10 Potential Multibagger Stocks To Buy Now
Kshitij Anand of ET has spoken to leading stock market experts and collated a list of ten stocks which have the potential to become multibagger stocks
Rahul Arora Of Nirmal Bang Foresees Mega Gains From Blue-Chip Pharma Stock
Rahul Arora of Nirmal Bang has recommended a blue-chip large-cap Pharma stock which has fallen from favour owing to USFDA issues. He claims that profits of the Company can “triple” and that the time is now opportune to buy the stock
NAMO’s Mishandling Of L’Affaire Raghuram Rajan Irks Stock Market Pundits
While eminent experts are divided in their opinion on whether Raghuram Rajan ought to have been offered a second term or not as RBI Governor, all are unanimous that NAMO handled the issue in a clumsy manner and has suffered a “self goal”
Gurus’ Wisdom Triumphs As NAMO’s Crackdown Of Taboo Sector Spooks Investors & Leads To Colossal Losses
Today, when panic-stricken investors were running helter-skelter due to NAMO’s knee-jerk crackdown over their favourite stocks, the Gurus had a benign smile. Their immense wisdom had spared them once again from calamity & carnage!
Model Portfolio Update By ICICI-Direct (Jan 2016)
ICICI’s Model Portfolio has heavily outperformed with an impressive return of 86.5% since June 2011. The Model Portfolio has been shuffled to take advantage of shifts in price of stocks and sectoral opportunities
Ace Stock Pickers Slam Intellectuals For ‘Intolerance’ Propaganda Against NAMO
The growing debate over alleged “intolerance” in the Country against minorities has aroused the ire of leading investors. There are mincing no words in blasting the intellectuals for the misleading propaganda which seeks to destabilize NAMO’s government and send the Country on the path of economic ruin
Recent Comments